Top

Molecular Cancer

Published in:

Open Access 01-12-2011 | Review

Papillomavirus E5: the smallest oncoprotein with many functions

Published in: Molecular Cancer | Issue 1/2011

Title: Papillomavirus E5: the smallest oncoprotein with many functions
Publication date: 01-12-2011
Published in: Molecular Cancer / Issue 1/2011
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-10-140

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2011

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy

RETRACTED ARTICLE:Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma

Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?

Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis

RNA polymerase III transcription in cancer: the BRF2 connection

Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression

Keynote webinar | Spotlight on antibody–drug conjugates in cancer